Erratum: Vol. 60, No. RR-1
Weekly / July 7, 2017 / 66(26);707
In the Recommendations and Reports “Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza” (January 21, 2011, Vol. 60, No. RR-1, https://www.cdc.gov/mmwr/pdf/rr/rr6001.pdfpdf icon), on page 8, in the first column, in the second paragraph, in the second sentence, the term “pneumonia” was used rather than “lower respiratory tract complications leading to antibiotic use.” The corrected sentence should read, “In a study that combined data from 10 clinical trials, the risk for lower respiratory tract complications leading to antibiotic use among those participants with laboratory-confirmed influenza receiving oseltamivir treatment was approximately 50% lower than among those persons receiving a placebo and 34% lower among patients at risk for complications (p<0.05 for both comparisons) (22).”
This correction does not change CDC’s influenza antiviral recommendations. A summary of current antiviral guidance is available at https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm.
Suggested citation for this article: Erratum: Vol. 60, No. RR-1. MMWR Morb Mortal Wkly Rep 2017;66:707. DOI: http://dx.doi.org/10.15585/mmwr.mm6626a7external icon.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
Questions or messages regarding errors in formatting should be addressed to email@example.com.